<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0602244855
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1980
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RITALIN TAB. 10MG
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        METHYLPHENIDATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Controlled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        29.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Siegfried Barbera S.L" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Siegfried Barbera S.L
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 439]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Novartis Saudi Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            NOVARTIS
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N06BA04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Ritalin is used to treat &lsquo;Attention Deficit Hyperactivity Disorder&rsquo; (ADHD).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is used in children and young people between the ages of 6 and 18.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is used only after trying treatments which do not involve medicines. Such as counselling and behavioural therapy.</p><p>Ritalin is not for use as a treatment for ADHD in children under 6 years of age or in adults. It is not known if it is safe or of benefit in these people.</p><p><strong>How it works</strong></p><p>Ritalin improves the activity of certain parts of the brain which are under-active. The medicine can help improve attention (attention span), concentration and reduce impulsive behaviour.</p><p>The medicine is given as part of a treatment programme, which usually includes:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; psychological</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; educational and</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; social therapy.</p><p>It is prescribed only by doctors who have experience in children or young people&rsquo;s behaviour problems. Although there is no cure for ADHD, it can be managed using treatment programmes.</p><p><strong>About ADHD</strong></p><p>Children and young people with ADHD find it:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hard to sit still and</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hard to concentrate.</p><p>It is not their fault that they cannot do these things.</p><p>Many children and young people struggle to do these things. However, with ADHD they can cause problems with everyday life. Children and young people with ADHD may have difficulty learning and doing homework. They find it hard to behave well at home, at school or in other places.</p><p>ADHD does not affect the intelligence of a child or young person.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>a. Do not take Ritalin:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are allergic (hypersensitive) to methylphenidate or any of the other ingredients of Ritalin (listed in Section 6)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a thyroid problem</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have increased pressure in your eye (glaucoma)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a tumour of your adrenal gland (phaeochromocytoma)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have an eating problem when you do not feel hungry or want to eat - such as &lsquo;anorexia nervosa&rsquo;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have very high blood pressure or narrowing of the blood vessels, which can cause pain in the arms and legs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have ever had heart problems - such as a heart attack, uneven heartbeat, pain and discomfort in the chest, heart failure, heart disease or were born with a heart problem</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have had a problem with the blood vessels in your brain - such as a stroke, swelling and weakening of part of a blood vessel (aneurysm), narrow or blocked blood vessels, or inflammation of the blood vessels (vasculitis)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have mental health problems such as:</p><p>-&nbsp;&nbsp;&nbsp; a &lsquo;psychopathic&rsquo; or &lsquo;borderline personality&rsquo; problem</p><p>-&nbsp;&nbsp;&nbsp; abnormal thoughts or visions or an illness called &lsquo;schizophrenia&rsquo;</p><p>-&nbsp;&nbsp;&nbsp; signs of a severe mood problem like:&nbsp;&nbsp;&nbsp;&nbsp;</p><p>o&nbsp; feeling like killing yourself</p><p>o&nbsp; severe depression, where you feel very sad, worthless and hopeless</p><p>o&nbsp; mania, where you feel unusually excitable, over-active, and un-inhibited.</p><p>Do not take Ritalin if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before you take Ritalin. This is because Ritalin can make these problems worse.</p><p>&nbsp;</p><p><strong>b. </strong><strong>Take special care with Ritalin </strong></p><p><strong>Check with your doctor or pharmacist before treatment if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; During treatment, boys and adolescents may unexpectedly experience prolonged erections. This may be painful and can occur at any time. It is important to contact your doctor straight away if your erection lasts for longer than 2 hours, particularly if this is painful.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have liver or kidney problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have<strong> </strong>had fits (seizures, convulsions, epilepsy) or any abnormal brain scans (EEGs)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have ever abused or been dependent on alcohol, prescription medicines or street</p><p>drugs</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are a girl and have started your&nbsp; periods (see the &lsquo;Pregnancy, breast-feeding and contraception&rsquo; section below)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have hard-to-control, repeated twitching of any parts of the body or you repeat sounds and words</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have high blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a heart problem which is not in the &lsquo;Do not take&rsquo; section above</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a mental health problem which is not in the &lsquo;Do not take&rsquo; section above. Other mental health problems include:</p><p>-&nbsp; mood swings (from being manic to being depressed - called &lsquo;bipolar disorder&rsquo;)</p><p>-&nbsp; starting to be aggressive or hostile, or your aggression gets worse</p><p>-&nbsp; seeing, hearing or feeling things that are not there (hallucinations)</p><p>-&nbsp; believing things that are not true (delusions)</p><p>-&nbsp; feeling unusually suspicious (paranoia)</p><p>-&nbsp; feeling agitated, anxious or tense</p><p>-&nbsp; feeling depressed or guilty.</p><p>&nbsp;</p><p>Tell your doctor or pharmacist if any of the above apply to you before starting treatment. This is because Ritalin can make these problems worse. Your doctor will want to monitor how the medicine affects you.</p><p><strong>&nbsp;</strong></p><p><strong>Checks that your doctor will make before you start taking Ritalin</strong></p><p>These checks are to decide if Ritalin is the correct medicine for you. Your doctor will talk to you about:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any other medicines you are taking</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; whether there is any family history of sudden unexplained death</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any other medical problems (such as heart problems) you or your family may have</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; how you are feeling, such as feeling high or low, having strange thoughts or if you have had any of these feelings in the past</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; whether there is a family history of &lsquo;tics&rsquo; (hard-to-control, repeated twitching of any parts of the body or repeating sounds and words)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; any mental health or behaviour problems you or other family members have ever had. Your doctor will discuss whether you are at risk of having mood swings (from being manic to being depressed - called &lsquo;bipolar disorder&rsquo;). They will check your mental health history, and check if any of your family have a history of suicide, bipolar disorder or depression.</p><p>&nbsp;</p><p>It is important that you provide as much information as you can. This will help your doctor decide if Ritalin is the correct medicine for you. Your doctor may decide that other medical tests are needed before you start taking this medicine.</p><p>&nbsp;</p><p><strong>C. Taking other medicines</strong><strong>, </strong><strong>herbal or dietary supplements</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.</p><p>Do not take Ritalin if you:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; are taking a medicine called a &lsquo;monoamine oxidase inhibitor&rsquo; (MAOI) used for depression, or have taken an MAOI in the last 14 days. Taking an MAOI with Ritalin may cause a sudden increase in your blood pressure.</p><p>If you are taking other medicines, Ritalin<em> </em>may affect how well they work or may cause side effects. If you are taking<strong> </strong>any of the following medicines, check with your doctor or pharmacist before taking<strong><em> </em></strong>Ritalin:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; other medicines for depression</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for severe mental health problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines for epilepsy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines used to reduce or increase blood pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; some cough and cold remedies which contain medicines that can affect blood pressure. It is important to check with your pharmacist when you buy any of these products</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; medicines that thin the blood to prevent blood clots</p><p>If you are in any doubt about whether any medicines you are taking are included in the list above, ask your doctor or pharmacist before taking Ritalin.</p><p>&nbsp;</p><p><strong>Having an operation</strong></p><p>Tell your doctor if you are going to have an operation. You should not take Ritalin<strong><em> </em></strong>on the day of your surgery if a certain type of anaesthetic is used. This is because there is a chance of a sudden rise in blood pressure during the operation.</p><p>&nbsp;</p><p><strong>Drug testing</strong></p><p>This medicine may give a positive result when testing for drug use. This includes testing used in sport.</p><p>&nbsp;</p><p><strong>d. Taking Ritalin with food and drink</strong></p><p>Taking Ritalin with food may help to stop stomach pains, feeling sick or being sick.</p><p><strong>&nbsp;</strong></p><p><strong>Taking Ritalin with alcohol</strong></p><p>Do not drink alcohol while taking this medicine. Alcohol may make the side effects of this medicine worse. Remember that some foods and medicines contain alcohol.</p><p>&nbsp;</p><p><strong>e. Pregnancy, breast-feeding </strong></p><p>Tell your doctor if you are pregnant or breast-feeding.</p><p>Ritalin/Ritalin LA should only be taken during pregnancy if you have been specifically instructed to do so by your doctor.</p><p>Talk to your doctor before using methylphenidate if you or your daughter:</p><p>&bull; Are pregnant or think you may be pregnant. Your doctor will decide whether methylphenidate should be taken.</p><p>Women should not breast-feed during treatment. The active substance of Ritalin can pass into the breast milk.</p><p><strong>&nbsp;</strong></p><p><strong>f. Driving or using machines</strong></p><p>You may feel dizzy, have problems focussing or have blurred vision when taking Ritalin. If these happen it may be dangerous to do things such as drive, use machines, ride a bike or horse or climb trees.</p><p>&nbsp;</p><p><strong>g. Important information about some of the ingredients of Ritalin</strong></p><p>This medicine contains lactose (a type of sugar). If you have been told by your doctor that you cannot tolerate or digest some sugars, talk to your doctor before taking this medicine.</p><p>This medicine contains wheat starch. If you have chronic fatty diarrhoea (but not coeliac disease), you should not take Ritalin.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>How much to take</strong></p><p>Always take Ritalin exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; your doctor will usually start treatment with a low dose and increase it gradually as required.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the maximum daily dose is 60 mg.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; take Ritalin once or twice daily (e.g. at breakfast or/and lunchtime).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the tablets should be swallowed with a drink of water.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you can break the tablets to make it easier to swallow.</p><p><strong>If you do not feel better after 1 month of treatment.&nbsp; </strong></p><p>If you do not feel better, tell your doctor. They may decide you need a different treatment.<strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p><strong>Not using Ritalin properly</strong></p><p>If Ritalin is not used properly, this may cause abnormal behaviour. It may also mean that you start to depend on the medicine. Tell your doctor if you have ever abused or been dependent on alcohol, prescription medicines or street drugs.</p><p>This medicine is only for you. Do not give this medicine to anyone else, even if their symptoms seem similar.</p><p><strong>a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>If you take more Ritalin than you should</strong></p><p>If you take too much medicine, talk to a doctor or call an ambulance straight away. Tell them how much has been taken.</p><p>Signs of overdose may include: being sick, feeling agitated, shaking, increased uncontrolled movements, muscle twitching, fits (may be followed by coma), feeling very happy, being confused, seeing, feeling or hearing things that are not real (hallucinations), sweating, flushing, headache, high fever, changes in heart beat (slow, fast or uneven), high blood pressure, dilated pupils, dry nose and mouth, muscle spasms, fever, red-brown urine which could be possible signs of abnormal breakdown of muscles (rhabdomyolysis).</p><p><strong>b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>If you forget to take Ritalin</strong></p><p>Do not take a double dose to make up for a forgotten dose. If you forget a dose, wait until it is time for the next dose.</p><p><strong>c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>If you stop taking Ritalin</strong></p><p>If you suddenly stop taking this medicine, the ADHD symptoms may come back or unwanted effects such as depression may appear. Your doctor may want to gradually reduce the amount of medicine taken each day, before stopping it completely. Talk to your doctor before stopping Ritalin.</p><p><strong>Things your doctor will do when you are on treatment</strong></p><p><strong>Your doctor will do some tests</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; before you start - to make sure that Ritalin is safe and will be of benefit.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; after you start - they will be done at least every 6 months, but possibly more often. They will also be done when the dose is changed.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; these tests will include:</p><p>-&nbsp;&nbsp; checking your appetite</p><p>-&nbsp;&nbsp; measuring height and weight</p><p>-&nbsp;&nbsp; measuring blood pressure and heart rate</p><p>-&nbsp;&nbsp; checking whether you have any problems with your mood, state of mind or any other unusual feelings. Or if these have got worse while taking Ritalin.</p><p><strong>Long-term treatment</strong></p><p>Ritalin does not need to be taken for ever. If you take Ritalin for more than a year, your doctor should stop treatment for a short time, this may happen during a school holiday. This will show if the medicine is still needed.</p><p>&nbsp;</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, methylphenidate can cause side effects, but not everybody gets them. Although some people get side effects, most people find that methylphenidate helps them. Your doctor will talk to you about these side effects.</p><p><strong>Some side effects could be serious. If you have any of the side effects below, see a doctor straight away:</strong></p><p><strong>Common </strong><strong>(affects less than 1 in 10 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; uneven heartbeat (palpitations)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; mood changes or mood swings or changes in personality</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; excessive teeth grinding (bruxism)</p><p><strong>Uncommon </strong><strong>(affects less than 1 in 100 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thinking about or feeling like killing yourself</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling, or hearing things that are not real, these are signs of psychosis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; uncontrolled speech and body movements (Tourette&rsquo;s)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; signs of allergy such as rash, itching or hives on the skin, swelling of the face, lips, tongue or other parts of the body, shortness of breath, wheezing or trouble breathing</p><p><strong>Rare </strong><strong>(affects less than 1 in 1,000 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling unusually excited, over-active and un-inhibited (mania)</p><p><strong>Very rare </strong><strong>(affects less than 1 in 10,000 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart attack</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fits (seizures, convulsions epilepsy)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; skin peeling or purplish red patches</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle spasms which you cannot control affecting your eyes, head, neck, body and nervous system -due to a temporary lack of blood supply to the brain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; paralysis or problems with movement and vision, difficulties in speech (these can be signs of problems with the blood vessels in your brain)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decrease in number of&nbsp; blood cells (red cells, white cells and platelets) which can make you more likely to get infections, and make you bleed and bruise more easily</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a sudden increase in body temperature, very high blood pressure and severe convulsions (&lsquo;Neuroleptic Malignant Syndrome&rsquo;). It is not certain that this side effect is caused by methylphenidate or other drugs that may be taken in combination with methylphenidate.</p><p><strong>Other side effects (how often they happen is not known)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp; unwanted thoughts that keep coming back</p><p>&middot;&nbsp;&nbsp;&nbsp; unexplained fainting, chest pain, shortness of breath (these can be signs of heart problems)</p><p>&middot;&nbsp;&nbsp;&nbsp; Prolonged erections, sometimes painful, or an increased number of erections</p><p>If you have any of the side effects above, see a doctor straight away.</p><p><strong>&nbsp;</strong></p><p><strong>Other side effects include the following, if they get serious, please tell your doctor or pharmacist:</strong></p><p><strong>Very common </strong><strong>(affects more than 1 in 10 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling nervous</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; not being able to sleep.</p><p><strong>Common </strong><strong>(affects less than 1 in 10 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; joint pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dry mouth</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high temperature (fever)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; unusual hair loss or thinning</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling unusually sleepy or drowsy</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; loss of appetite or decreased appetite</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; decreased weight</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itching, rash or raised red itchy rashes (hives)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cough, sore throat or nose and throat irritation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high blood pressure, fast&nbsp; heart beat (tachycardia)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling dizzy, movements which you cannot control, being unusually active</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling aggressive, agitated, anxious, depressed, irritable and abnormal behaviour</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stomach pain, diarrhoea, feeling sick, stomach discomfort and being sick . These usually occur at the beginning of treatment and may be reduced by taking the medicine with food.</p><p><strong>Uncommon </strong><strong>(affects less than 1 in 100 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; constipation</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chest discomfort</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blood in the urine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shaking and trembling</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; double vision or blurred vision</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle pain, muscle twitching</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath or chest pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increases in liver test results (seen in a blood test)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; anger, feeling restless or tearful,&nbsp; excessive awareness of surroundings, problems sleeping.</p><p><strong>Rare </strong><strong>(affects less than 1 in 1,000 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in sex drive</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling disorientated</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dilated pupils, trouble seeing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the breasts in men</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; excessive sweating, redness of the skin, red raised skin rash</p><p><strong>Very rare </strong><strong>(affects less than 1 in 10,000 people)</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart attack</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sudden death</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle cramps</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; small red marks on the skin</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inflammation or blocked arteries in the brain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; abnormal liver function including liver failure and coma</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in test results &ndash; including liver and blood tests</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; suicidal attempt, abnormal thinking, lack of feeling or emotion, doing things over and over again, being obsessed with one thing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fingers and toes feeling numb, tingling and changing colour (from white to blue, then red)&nbsp; when cold (&lsquo;Raynaud&rsquo;s phenomenon&rsquo;)</p><p><strong>Other side effects (how often they happen is not known):</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; migraine</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; very high fever</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; slow, fast or extra heart beats&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a major fit (&lsquo;grand mal convulsions&rsquo;)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; believing things that are not true, confusion</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe stomach pain, often with feeling and being sick</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; problems with the blood vessels of the brain (stroke, cerebral arteritis or cerebral occlusion)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; erectile dysfunction</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; excessive uncontrolled talking</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inability to control the excretion of urine (incontinence)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; spasm of the jaw muscles that makes it difficult to open the mouth (trismus)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; stuttering</p><p>&bull; Epistaxis.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Effects on growth </strong></p><p>When used for more than a year, methylphenidate may cause reduced growth in some children. This affects less than 1 in 10 children.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There may be lack of weight gain or height growth.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your doctor will carefully watch your height and weight, as well as how well you are eating.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are not growing as expected, then your treatment with methylphenidate may be stopped for a short time.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Make sure you keep your medicine in a safe place, so that no one else takes it, especially younger brothers or sisters.</p><p>&nbsp;</p><p>Do not use Ritalin after the expiry date which is stated on the label. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Do not store above 30&deg;C. Store in the original package in order to protect from moisture</p><p>&nbsp;</p><p>Keep this medicine out of sight and reach of children.</p><p>&nbsp;</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is methylphenidate hydrochloride.</p><p>Ritalin tablets contain 10 mg of methylphenidate hydrochloride.</p><p>&nbsp;</p><p>The other ingredients are: calcium phosphate, lactose, wheat starch, gelatine,&nbsp; magnesium stearate, talc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Ritalin Tablets are available in one strength: 10 mg. 

The medicinal product is available in blister packs containing 20, 30, or 50 tablets.
Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The Marketing Authorization Holder for this Product is Novartis Pharma AG.</p><p>www.Novartis.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised by Swissmedic in December 2022.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>فيم يُستخدم؟</strong></p><p dir="RTL">يُستخدم عقار ريتالين لعلاج &quot;اضطراب نقص الانتباه مع فرط النَّشاط&quot;.</p><ul><li dir="RTL">ويُستخدم في الأطفال والشباب الصغار الذين تتراوح أعمارهم بين 6 و 18 عامًا.</li><li dir="RTL">لا يتم استخدامه إِلَّا بعد تجربة العلاجات التي لا تحتوي على أدوية. مثل المشورة والعلاج السلوكي.</li></ul><p dir="RTL">لا يُستخدم عقار ريتالين كعلاج لاضطراب نقص الانتباه مع فرط النَّشاط في الأطفال بعمر أقل من 6 سنوات أو في البالغين. من غير المعروف ما إذا كان آمنا أو له فوائد في هؤلاء الأشخاص أم لا.</p><p dir="RTL"><strong>كيفية عمله</strong></p><p dir="RTL">يُحسن عقار ريتالين من نشاط أجزاء معينة من المخ والتي يوجد بها قصور. من الممكن أن يُساعد الدَّواء في تحسين الانتباه (مدى الانتباه)، والتركيز والحد من السلوك الاندفاعي.</p><p dir="RTL">يتم إعطاء الدَّواء كجزء من برنامج &nbsp;علاجي، والذي يشمل عادةً:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العلاج النفسي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; والتعليمي</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; والاجتماعي.</p><p dir="RTL">لا يتم وصف العلاج إِلَّا من قبل الأطباء الذين لديهم خبرة في المشاكل السلوكية لدى الأطفال أو الشباب الصغار.&nbsp; على الرَّغم من عدم وجود علاج لاضطراب نقص الانتباه مع فرط النَّشاط، فمن الممكن تدبير علاجه باستخدام برامج العلاج.</p><p dir="RTL"><strong>حول اضطراب نقص الانتباه مع فرط النشاط</strong></p><p dir="RTL">يجد الأطفال والشباب الصغار الذين يعانون من اضطراب نقص الانتباه مع فرط النَّشاط الآتي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في الثبات بالجلوس.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وصعوبة في التركيز.</p><p dir="RTL">ليس خطأهم أنهم لا يستطيعون القيام بهذه الأمور.</p><p dir="RTL">يجد العديد من الأطفال والشباب الصغار مقاومة للقيام بهذه الأمور. مع ذلك، من الممكن أن تُؤدي الإصابة باضطراب نقص الانتباه مع فرط النَّشاط إلى حدوث مشاكل بالحياة اليومية. قد يواجه الأطفال والشباب الصغار الذين يعانون من اضطراب نقص الانتباه مع فرط النَّشاط صعوبة في التَّعلم والقيام بالواجبات المنزلية. فهم يجدون صعوبة في التَّصرف بشكل جيد في المنزل، أو المدرسة أو في الأماكن الأخرى.</p><p dir="RTL">لا يُؤثر اضطراب نقص الانتباه مع فرط النَّشاط على ذكاء الأطفال أو الشباب الصغار.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>أ&zwnj;.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>موانع استعمال عقار ريتالين:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من الحساسية (الحساسية المفرطة) تجاه ميثيل فينيديت أو أيٍّ من المكونات الأخرى بعقار ريتالين (المُدرَجة في قسم: 6).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك مشاكل بالغدة الدَّرقية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من ارتفاع الضَّغط بداخل عينك (الجلوكوما [المياه الزرقاء]).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بورم في الغدة الكظرية لديك (ورم القواتم).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشكلة بالأكل عندما لا تشعر بالجوع أو لا ترغب في الأكل -مثل: &quot;فقدان الشهية العصبي&quot;.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من ارتفاع ضغط الدَّم الشَّديد أو تضيُق الأوعية الدَّموية، والذي من الممكن أن يسبب ألمًا في الذراعين والسَّاقين.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد عانيت من قبل من مشاكل في القلب -مثل: نوبة قلبية، عدم انتظام ضربات القلب، ألم وضيق بالصدر، فشل القلب، مرض بالقلب، كان لديك مشكلة بالقلب منذ الولادة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد كانت لديك مشكلة بالأوعية الدَّموية في المخ لديك -مثل: سكتة دماغية، تورم وضعف جزء من الأوعية الدَّموية (تمدد الأوعية الدَّموية)، تضيُّق أو انسداد الأوعية الدَّموية، أو التهاب الأوعية الدَّموية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل متعلقة بالصحة النفسية مثل:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشكلة &quot;اعتلال نفسي&quot; أو &quot;شخصية حدية&quot;.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أفكار أو رؤى غير طبيعية أو مرض يُسمى: &quot;الفُصَام&quot;.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علامات على حدوث مشكلة شديدة بالحالة المزاجية مثل:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور شبيه بالانتحار.</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاكتئاب الشَّديد؛ حيث تشعر بحزن شديد، وأنك عديم القيمة ويائس.</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الهوس؛ حيث تشعر بإثارة، إفراط في النَّشاط، وعدم كبت بطريقة غير معتادة.</p><p dir="RTL">لا تتناول ريتالين إذا كان أي مما سبق ينطبق عليك. إذا لم تكن متأكدًا، تحدَّث مع طبيبك أو الصيدلي الخاص بك قبل تناول ريتالين. هذا لأنَّ ريتالين من الممكن أن يجعل هذه المشاكل تتفاقم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ب&zwnj;.&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الاحتياطات عند استعمال عقار ريتالين:</strong></p><p dir="RTL"><strong>راجع طبيبك أو الصيدلي الخاص بك قبل العلاج في الحالات التَّالية:</strong></p><ul><li dir="RTL">أثناء العلاج، قد يعاني الأولاد والمراهقون من الانتصاب لفترات طويلة بشكل غير متوقع. قد يكون هذا مؤلمًا ومن الممكن أن يحدث في أي وقت. من الهام الاتصال بطبيبك فورًا إذا دام الانتصاب لديك لأكثر من ساعتين، وخاصَّة إذا كان هذا مؤلمًا.</li></ul><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك مشاكل بالكبد أو الكلى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد أصبت بنوبات (نوبات تشنجية، تشنجات، صرع) أو قد كان لديك أي فحص غير طبيعي بالمخ (مخطط كهربية الدماغ).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد أدمنت استخدام الكحوليات أو كنت تعتمد عليها من قبل، أو الأدوية الوصفية أو المخدرات التي يتم بيعها بالشَّارع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ فتاة وقد بدأت لديكِ دورات الطمث (انظري قسم: &quot;الحمل والرضاعة الطبيعية وموانع الحمل&quot; أدناه).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك صعوبة في السيطرة، انتفاض عضلي متكرر في أي أجزاء من الجسم أو كنت تكرر الأصوات والكلمات.&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تُعاني من ارتفاع ضغط الدَّم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك مشكلة بالقلب لم تندرج بقسم &quot;لا تتناول&quot; أعلاه.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كانت لديك مشكلة متعلقة بالصحة النفسية لم تندرج بقسم &quot;لا تتناول&quot; أعلاه. تشمل المشاكل المتعلقة بالصحة النفسية الأخرى ما يلي:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقلبات الحالة المزاجية (من الهوس إلى الاكتئاب -يُسمى: &quot;الاضطراب ثنائي القطب&quot;).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بدء التَّصرف بشراسة أو عدوانية، أو تفاقم العدوانية لديك.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رؤية، سماع أو الشعور بأشياء غير موجودة (الهلوسة).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تصديق أشياء غير صحيحة (الأوهام).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بارتياب بطريقة غير عادية. (جنون ارتياب).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بهياج، أو قلق أو توتر.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور باكتئاب أو الشعور بالذنب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك أو الصيدلي الخاص بك إذا كان أي مما سبق ينطبق عليك قبل بدء العلاج. هذا لأنَّ ريتالين من الممكن أن يجعل هذه المشاكل تتفاقم. سيرغب طبيبك في مراقبة مدى تأثير الدَّواء عليك.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الفحوصات التي سيقوم طبيبك بإجرائها قبل بدء تناولك لل</strong><strong>ريتالين</strong></p><p dir="RTL">يتم إجراء هذه الفحوصات؛ لتقرير ما إذا كان ريتالين هو الدَّواء الصحيح لك أم لا. سيتحدَّث إليك طبيبك حول الآتي:</p><ul><li dir="RTL">أية أدوية أخرى تتناولها.</li><li dir="RTL">ما إذا كان هناك أي تاريخ عائلي &nbsp;لحدوث &nbsp;وفاة &nbsp;مفاجئة غير &nbsp;مفسرة.</li><li dir="RTL">أية مشاكل صحية أخرى (مثل مشاكل القلب) قد تكون لديك أو لدى أي من أفراد عائلتك.</li><li dir="RTL">كيفية شعورك، مثل: الشعور بالسعادة أو الاكتئاب، أو إذا كانت تراودك أفكار غريبة أو إذا كنت قد&nbsp; عانيت من هذه المشاعر في الماضي.</li><li dir="RTL">ما إذا كان هناك تاريخ عائلي من الإصابة &quot;بالتشنجات اللا إرادية&quot; (صعوبة في السيطرة، انتفاض عضلي متكرر في أي أجزاء من الجسم أو تكرار الأصوات والكلمات).&nbsp;</li><li dir="RTL">أي مشاكل متعلقة بالصحة النفسية أو مشاكل سلوكية قد عانيت منها من قبل أنت أو أي من أفراد عائلتك. سيناقش طبيبك ما إذا كنت معرضًا لخطر حدوث تقلبات بالحالة المزاجية (من الهوس إلى الاكتئاب -يسمى &quot;الاضطراب ثنائي القطب&quot;). سيقومون بالتَّحقق من تاريخ الصحة النفسية لديك، وسيتحققون مما إذا كان أي من أفراد عائلتك لديه تاريخ من حدوث الانتحار، أو الإصابة بالاضْطِّراب ثنائي القطب أو الاكتئاب.</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">من الهام أن تقدم أكبر قدر ممكن من المعلومات. سيُساعد هذا طبيبك في تقرير ما إذا كان ريتالين هو الدَّواء الصحيح لك أم لا. قد يقرر طبيبك وجود حاجة إلى إجراء اختبارات طبية أخرى قبل بدئك في تناول هذا الدَّواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ج. التداخلات الدوائية من أخذ عقار ريتالين مع أدوية أخرى أو أعشاب أو مكملات غذائية</strong></p><p dir="RTL">يُرجى إبلاغ طبيبك أو الصيدلي الخاص بك إذا كنت تتناول أو تناولت مؤخرًا أية أدوية أخرى، بما في ذلك الأدوية التي حصلت عليها دون وصفة طبية.</p><p dir="RTL">لا تتناول ريتالين في الحالات الآتية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تتناول دواءً يُسمى: &quot;مثبط أوكسيديز أحادي الأمين&quot; الذي يُستخدم لعلاج الاكتئاب، أو قد تناولت مثبط أوكسيديز أحادي الأمين في الـ14 يومًا الأخيرة. قد يُؤدي تناول أحد مثبطات أوكسيديز أحادي الأمين مع ريتالين إلى ارتفاع مفاجئ في ضغط الدَّم لديك.</p><p dir="RTL">إذا كنت تتناول أدوية أخرى، فقد يُؤثر ريتالين على مدى كفاءة عملها أو قد يُسبب آثارًا جانبية. أخبر طبيبك أو الصيدلي الخاص بك قبل تناول ريتالين إذا كنت تتناول أيًّا من الأدوية التَّالية:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية أخرى لعلاج الاكتئاب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية لعلاج المشاكل المتعلقة بالصحة النفسية الشديدة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية لعلاج الصرع.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تُستخدم &nbsp;لخفض أو زيادة ضغط الدَّم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعض علاجات السعال والبرد التي تحتوي على &nbsp;أدوية من الممكن أن تُؤثر على ضغط الدَّم. من المهم التَّحقق مع الصيدلي الخاص بك عندما تشتري أيًّا من هذه المنتجات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تعمل على إسالة الدَّم؛ لمنع تكَوُّن الجلطات.</p><p dir="RTL">إذا كان لديك أي شك حول ما إذا كان أي من الأدوية التي تتناولها تندرج في القائمة أعلاه أم لا، استشر طبيبك أو الصيدلي الخاص بك قبل تناوُل ريتالين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الخضوع للجراحة</strong></p><p dir="RTL">أخبر طبيبك إذا كنت بصدد الخضوع لعملية جراحية. يجب عليك عدم تناول ريتالين في يوم إجراء الجراحة إذا تم استخدام نوع معين من أدوية التَّخدير. وهذا لأنَّ هناك فرصة لحدوث ارتفاع مفاجئ في ضغط الدَّم أثناء إجراء الجراحة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>اختبار المخدرات</strong></p><p dir="RTL">قد يعطي هذا الدَّواء نتيجة إيجابية عند إجراء اختبار الكشف عن تناول المخدرات. ويشمل هذا الاختبار المستخدم في الرياضة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>د. تناوُل </strong><strong>ريتالين</strong><strong> مع الطعام والشراب</strong></p><p dir="RTL">قد يُساعد تناول ريتالين مع الطعام على إيقاف آلام المعدة، أو الشعور بالإعياء أو الإعياء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تناول </strong><strong>ريتالين</strong><strong> مع الكحوليات</strong></p><p dir="RTL">لا تشرب الكحوليات أثناء تناول هذا الدَّواء. قد يعمل تناول الكحوليات على تفاقم الآثار الجانبية لهذا الدَّواء. تذكر أنَّ بعض الأطعمة والأدوية تحتوي على الكحوليات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>هـ. الحمل والرَّضاعة </strong></p><p dir="RTL">أخبري طبيبكِ إذا كنتِ حاملاً أو مرضعة.</p><p dir="RTL">يجب ألا يتم تناول عقار ريتالين أثناء الحمل إلا إذا تم توجيهك على وجه التحديد للقيام بذلك من قبل طبيبك.</p><p dir="RTL">تحدثِ إلى طبيبك قبل استخدام ميثيلفينيديت إذا كنتِ أنتِ أو ابنتك:</p><p dir="RTL">&bull; حامل أو تعتقدي بأنك حامل. سيقرر طبيبك ما إذا كان يجب تناول ميثيلفينيديت.</p><p dir="RTL">يجب على النساء عدم الرضاعة الطبيعية أثناء العلاج، يمكن أن تنتقل المادة الفعالة من ريتالين إلى حليب الثدي.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>و. تأثير عقار ريتالين على القيادة واستخدام الآلات</strong></p><p dir="RTL">قد تشعر بدوخة أو قد يكون لديك مشاكل بالتركيز أو قد تصاب بعدم وضوح الرؤية أثناء تناول ريتالين. إذا حدثت هذه الأعراض فقد يكون من الخطر القيام بأشياء مثل: ممارسة القيادة، أو استخدام الآلات أو ركوب الدراجات أو الخيل أو تسلق الأشجار.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>ز. معلومات هامَّة حول بعض مكونات عقار ريتالين</strong></p><p dir="RTL">يحتوي هذا الدَّواء على لاكتوز (نوع من أنواع السكر). إذا كان طبيبك قد أخبرك بأنك لا تستطيع تحمل بعض أنواع السكريات أو هضمها، فتحدث إليه قبل تناول هذا الدَّواء.</p><p dir="RTL">يحتوي هذا الدَّواء على نشا القمح. إذا كنت مصابًا بالإسهال الدهني المزمن (ولكن ليس الاضطراب الهضمي الزلاقي)، فيجب عليك عدم تناول عقار ريتالين.&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ما الكمية التي يجب أن تتناولها؟</strong></p><p dir="RTL">تناول عقار ريتالين دائمًا كما أخبرك طبيبك بالضبط. راجع طبيبك أو الصيدلي الخاص بك إذا لم تكن متأكدًا من كيفية الاستخدام.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيبدأ طبيبك العلاج عادةً بجرعة منخفضة وسيقوم بزيادتها تدريجيًّا على النحو المطلوب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة اليومية القصوى هي 60 مجم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول عقار ريتالين مرة واحدة أو مرتين يوميًّا (على سبيل المثال: عند الإفطار و/ أو الغداء).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب بلع الأقراص مع شرب الماء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكنك تقسيم الأقراص؛ ليكون ابتلاعها أسهل.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا لم تشعر بتحسن بعد شهر واحد من العلاج.&nbsp; </strong></p><p dir="RTL">إذا لم تشعر بتحسن، فأخبر طبيبك. قد يقرر حاجتك إلى علاج مختلف.<strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>عدم استخدام عقار ريتالين بشكل صحيح</strong></p><p dir="RTL">إذا لم يتم استخدام عقار ريتالين بشكل صحيح، فقد يُسبب ذلك سلوكًا غير طبيعي. قد يعني أيضًا أنك بدأت الاعتماد على العلاج. أخبر طبيبك إذا كنت قد أدمنت استخدام الكحوليات أو كنت تعتمد عليها من قبل، أو الأدوية الوصفية أو المخدرات التي يتم بيعها بالشَّارع.</p><p dir="RTL">تم وصف هذا الدَّواء لك وحدك، لا تعطِ هذا الدَّواء لأي شخص آخر، حتى إذا كانت&nbsp; أعراضهم &nbsp;تبدو متشابهة.</p><p dir="RTL"><strong>أ&zwnj;.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>الجرعة الزائدة من عقار ريتالين</strong></p><p dir="RTL">إذا تناولت كمية كبيرة من الدَّواء، فتحدَّث إلى الطبيب أو اتصل بالإسعاف فورًا. أخبرهم بكمية الدَّواء التي تناولتها.</p><p dir="RTL">قد تشمل أعراض الجرعة الزَّائدة ما يلي: إعياء، شعورًا بالهياج، ارتجافًا، زيادة الحركات غير المنضبطة، انتفاضًا عضليًّا، نوبات تشنجية (قد تُتبع بغيبوبة)، الشعور بأنك سعيد جدًّا، ارتباكًا، رؤية أو سماع أو الشعور بأشياء غير حقيقية (الهلاوس)، تعرقًا، احمرار الجلد، صداعًا، حمى مرتفعة، تغيرات في معدل ضربات القلب (بطء أو سرعة أو عدم انتظام ضربات القلب)، ارتفاع ضغط الدَّم، اتساع حدقات العين، وجفاف الأنف والفم، تقلصات عضلية، حمى، تبول بول أحمر يميل إلى البني وقد تكون هذه علامات على انحلال غير طبيعي بالعضلات (انحلال الربيدات).</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>ب. نسيان تناول جرعة من عقار ريتالين</strong></p><p dir="RTL">لا تتناول جرعة مضاعفة لتعويض جرعة أغفلتها. إذا أغفلت إحدى الجرعات، فانتظر حتى يحين موعد الجرعة التَّالية.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>ج. التوقف عن تناول عقار ريتالين</strong></p><p dir="RTL">إذا توقفت فجأة عن تناول هذا الدَّواء، فقد تعود أعراض اضطراب نقص الانتباه مع فرط النَّشاط مرة أخرى أو قد تظهر آثار غير مرغوب فيها مثل: الاكتئاب. قد يرغب طبيبك في تقليل كمية الدَّواء التي يتم تناولها كل يوم تدريجيًّا، قبل إيقافه تمامًا. تحدَّث إلى طبيبك قبل وقف عقار ريتالين.</p><p dir="RTL"><strong>الأشياء التي سيفعلها طبيبك أثناء علاجك</strong></p><p dir="RTL"><strong>سيقوم طبيبك بإجراء بعض الاختبارات</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قبل أن تبدأ العلاج -للتأكد من أنَّ عقار ريتالين آمن وأنه سيكون مفيدًا لك.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بعد أن تبدأ العلاج -سيتم إجراؤها كل 6 أشهر على الأقل، ولكن ربما بشكل أكثر في كثير من الأحيان. سيتم إجراؤها أيضًا عند تغيير الجرعة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ستشمل هذه الاختبارات ما يلي:</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>التَّحقق من شهيتك.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>قياس الطول والوزن.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>قياس ضغط الدَّم ومعدل ضربات القلب.</p><p dir="RTL"><strong>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>التَّحقق مما إذا كان لديك أي مشاكل بالحالة المزاجية، أو الحالة الذهنية أو أي مشاعر غير عادية أخرى. أو إذا تفاقمت هذه الأعراض أثناء تناول عقار ريتالين.</p><p dir="RTL"><strong>العلاج طويل الأمد</strong></p><p dir="RTL">ليست هناك حاجة لتناول عقار ريتالين مدى الحياة. إذا تناولت عقار ريتالين لأكثر من سنة واحدة، يجب على طبيبك إيقاف العلاج لمدة قصيرة، وقد يحدث ذلك أثناء الإجازة المدرسية. سيبين هذا إذا كان لا يزال هناك حاجة إلى الدَّواء أم لا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كانت لديك أية أسئلة إضافية حول استخدام هذا المنتج، فاستشر طبيبك أو الصيدلي الخاص بك.</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثله مثل كافة الأدوية، قد يُسبب ميثيل فينيديت آثارًا جانبية، على الرغم من عدم حدوثها لدى الجميع. على الرَّغم من حدوث الآثار الجانبية لبعض الأشخاص، فإنَّ معظم الأشخاص يجدون أن ميثيل فينيديت يقوم بمساعدتهم. سيتحدَّث إليك طبيبك بشأن هذه الآثار الجانبية.</p><p dir="RTL"><strong>بعض الآثار الجانبية قد تكون خطيرة</strong><strong>. </strong><strong>إذا كان لديك أي من الآثار الجانبية أدناه، قم بزيارة الطبيب فورًا</strong><strong>:</strong></p><p dir="RTL"><strong>شائعة</strong> <strong>(</strong><strong>تؤثر على أقل من شخص واحد من بين كل </strong><strong>10 </strong><strong>أشخاص</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم انتظام ضربات القلب (خفقان).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حدوث تغيرات في الحالة المزاجية أو تقلبات بالحالة المزاجية أو تغيرات في الشَّخصية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صريف الأسنان المفرط.</p><p dir="RTL"><strong>غير شائعة </strong><strong>(</strong><strong>تؤثر على أقل من شخص واحد من بين كل </strong><strong>100 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التفكير بالانتحار أو الشعور بالرغبة في الانتحار.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بأشياء أو سماع أصوات أشياء غير حقيقية، هذه علامات الإصابة بالذهان.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الكلام وحركات الجسم غير المتحكم بهما (متلازمة توريت).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علامات الحساسية مثل الطفح الجلدي، الحكة، الشرى (الأرتكاريا) على الجلد، تورم الوجه أو الشفتين أو اللسان أو أجزاء أخرى من الجسم، ضيق التنفس، أزيز بالصدر أو صعوبة التنفس.</p><p dir="RTL"><strong>نادرة</strong> <strong>(</strong><strong>تؤثر على أقل من شخص واحد من بين كل </strong><strong>1000 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بإثارة وفرط نشاط واستهتار بطريقة غير معتادة (هوس).</p><p dir="RTL"><strong>نادرة جدًّا </strong><strong>(</strong><strong>تؤثر على أقل من شخص واحد من بين كل </strong><strong>10000 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبة قلبية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبات (نوبات تشنجية، تشنجات، صرع).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقشر الجلد أو وجود بقع حمراء أرجوانية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقلصات عضلية لا يمكنك التحكم بها وتؤثر على عينيك، رأسك، رقبتك، جسمك والجهاز العصبي لديك -بسبب نقص إمداد المخ بالدم بشكل مؤقت.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شلل أو مشاكل بالحركة والرؤية، صعوبات في الكلام (قد تكون هذه علامات على حدوث مشاكل بالأوعية الدَّموية في المخ لديك).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد خلايا الدَّم (الخلايا الحمراء، والخلايا البيضاء والصفائح الدَّموية) والذي من الممكن أن يجعلك أكثر عُرضة للإصابة بالعدوى، ويجعلك تتعرض للنزيف والكدمات بسهولة أكبر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مفاجئة في درجة حرارة الجسم، ارتفاع ضغط الدَّم الشديد، والتشنجات الشَّديدة (&quot;المُتَلازِمَة الخَبيثَة للدَّواءِ المُضادِّ للذُّهان&quot;). من غير المؤكد أن يكون هذا الأثر الجانبي ناجمًا عن ميثيل فينيديت أو العقاقير الأخرى التي قد يكون تم تناولها بمصاحبة ميثيل فينيديت.</p><p dir="RTL"><strong>آثار جانبية أخرى </strong><strong>(</strong><strong>عدد مرات حدوثها غير معروف</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أفكار غير مرغوب فيها وتعود بشكل مستمر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إغماء غير مُفسر، ألم في الصدر، ضيق التنفس (قد تكون هذه علامات على وجود مشاكل بالقلب).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتصاب لفترة طويلة، وأحيانًا يكون مؤلمًا، أو زيادة عدد مرات حدوث الانتصاب.</p><p dir="RTL">إذا كان لديك أي من الآثار الجانبية أعلاه، قم بزيارة الطبيب فورًا.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تشمل الآثار الجانبية الأخرى ما يلي، إذا أصبحت خطيرة، يُرجى إخبار طبيبك أو الصيدلي الخاص بك</strong><strong>:</strong></p><p dir="RTL"><strong>شائعة جدًّا </strong><strong>(</strong><strong>تؤثر على أكثر من شخص واحد من بين كل </strong><strong>10&nbsp;</strong><strong>أشخاص</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداعًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالتوتر/ العصبية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم القدرة على النوم.</p><p dir="RTL"><strong>شائعة</strong> <strong>(</strong><strong>تؤثر على أقل من شخص واحد من بين كل </strong><strong>10 </strong><strong>أشخاص</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلامًا بالمفاصل.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع درجة الحرارة (حمى).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ترقق أو تساقط الشعر بشكل غير معتاد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالنوم أو النعاس بشكل غير معتاد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية أو انخفاض الشهية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض الوزن.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة، طفحًا جلديًّا أو طفحًا جلديًّا بارزًا مصحوبًا باحمرار وحكة (شرى (أرتكاريا)).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سعالًا، التهاب الحلق، أو تهيُّج الأنف والحلق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع ضغط الدَّم، سرعة ضربات القلب (تسارع ضربات القَلْب).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعورًا بالدوخة، حركات لا يمكن التَّحكم بها، نشاطًا بشكل غير معتاد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالعدوانية، الهياج، القلق، الاكتئاب، العصبية والسلوك غير الطبيعي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألمًا بالمعدة، إسهالًا، شعورًا بالإعياء، الشعور بعدم الرَّاحة في المعدة، والإعياء. تحدث هذه الآثار عادةً عند بداية العلاج ويمكن الحد منها عن طريق تناوُل الدَّواء مع الطعام.</p><p dir="RTL"><strong>غير شائعة </strong><strong>(</strong><strong>تؤثر على أقل من شخص واحد من بين كل </strong><strong>100 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إمساكًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيقًا بالصدر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود دم في البول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتجافًا وارتعاشًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ازدواج الرؤية أو عدم وضوح الرؤية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألمًا في العضلات، انتفاضًا عضليًّا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق التنفس أو ألمًا في الصدر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادات في نتائج اختبارات الكبد (لُوحظت في اختبارات الدَّم).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غضبًا، شعورًا بالتململ أو البكاء، وعيًا مفرطًا بالبيئة المحيطة، مشاكل في النوم.</p><p dir="RTL"><strong>نادرة</strong> <strong>(</strong><strong>تؤثر على أقل من شخص واحد من بين كل </strong><strong>1000 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في الرغبة الجنسية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعورًا بتوهان.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتساع حدقة العين، صعوبات في الرؤية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورُّم الثدي لدى الرجال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعرقًا مفرطًا، احمرار الجلد، طفحًا جلديًّا أحمر وبارزًا.</p><p dir="RTL"><strong>نادرة جدًّا </strong><strong>(</strong><strong>تؤثر على أقل من شخص واحد من بين كل </strong><strong>10000 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبة قلبية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وفاة مفاجئة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقلصات عضلية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; علامات حمراء صغيرة على الجلد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب أو انسداد الشرايين الموجودة في المخ.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب وظائف الكبد بما في ذلك فشل الكبد والغيبوبة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في نتائج الاختبارات &ndash; بما في ذلك اختبارات الدَّم والكبد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; محاولة الانتحار، التفكير غير الطبيعي، قصورًا بالإحساس أو الشعور، فعل الأشياء مرارًا وتكرارًا، الهوس بشيء واحد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بتنميل ووخز وتغير اللون (من اللون الأبيض إلى الأزرق، ثم الأحمر) في أصابع اليدين والقدمين أثناء البرد (&quot;ظاهِرَة رينود&quot;).</p><p dir="RTL"><strong>آثار جانبية أخرى </strong><strong>(</strong><strong>عدد مرات حدوثها غير معروف</strong><strong>):</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع النصفي.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى مرتفعة جدًّا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بطء أو سرعة أو زيادة معدل ضربات القلب.&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبة تشنجية رئيسية (&quot;تشنجات الصرع الكبير&quot;).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تصديق أشياء غير صحيحة، ارتباكًا/ التباسًا.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألمًا شديدًا بالمعدة، يكون غالبًا مع الشعور بالإعياء أو الإعياء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل بالأوعية الدَّموية بالمخ (سكتة دماغية، التهاب الشرايين الدماغية أو انسدادها).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطرابات بالانتصاب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط الكلام غير المنضبط.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم القدرة على التحكم في التخلص من البول (سلس البول).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تقلصات بعضلات الفك التي تجعل من الصعب فتح الفم (ضَزَز).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التَّلَعثُم (التأتأة).</p><p dir="RTL">&bull; رُ عاف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التَّأثيرات على النمو </strong></p><p dir="RTL">عند استخدام ميثيل فينيديت لأكثر من عام، فقد يُسبب انخفاض النمو في بعض الأطفال. يُؤثر ذلك على أقل من طفل واحد من بين كل 10 أطفال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يكون هناك انخفاض في اكتساب الوزن أو نمو الطول.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سيقوم طبيبك بمراقبة طولك ووزنك بعناية، وكذلك كيفية تناولك للطعام.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت لا تنمو على النحو المتوقع، حينئذ قد يتم إيقاف علاجك بميثيل فينيديت لفترة قصيرة من الوقت.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تأكد من حفظ الدَّواء الخاص بك في مكان آمن، حتى لا يتناوله أي شخص آخر، وخاصة الأشقاء أو الشقيقات الأصغر سنًّا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم عقار ريتالين بعد انتهاء تاريخ الصلاحية المدون على الملصق. يُشير تاريخ انتهاء الصَّلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تقم بالتَّخزين في درجة حرارة تتعدى 30 درجة مئوية. يخزن في العبوة الأصلية للحماية من الرطوبة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يُحفظ هذا الدَّواء بعيدًا عن رؤية ومُتناوَل الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب عدم التَّخلص من الأدوية عن طريق مياه الصرف أو مع المخلفات المنزلية. اسأل الصيدلي الخاص بك عن كيفية التَّخلص من الأدوية التي لم تعد بحاجة إليها. ستُساعد هذه التَّدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي: هيدروكلوريد ميثيل فينيديت</p><p dir="RTL">تحتوي أقراص عقار ريتالين على 10 مجم من هيدروكلوريد ميثيل فينيديت</p><p dir="RTL">&nbsp;</p><p dir="RTL">المكونات الأخرى هي: فوسفات الكالسيوم، لاكتوز، نشا القمح، جيلاتين، ستيرات الماغنسيوم وتلك.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تتوفر أقراص عقار ريتالين بتركيز واحد: 10 مجم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتوافر المنتج الدَّوائي في عبوات شرائط تحتوي على 20، 30، أو 50 قرصًا.</p><p dir="RTL">قد لا يتم تسويق جميع أحجام العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مالك حق التّسويق لهذا المنتج هي شركة نوفارتس فارما إيه جي.</p><p dir="RTL">www.Novartis.com</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            ‌د.	تمت آخر مراجعة لهذه النَّشرة من قبل سويسرا في ديسمبر 2022


        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ritalin 10mg Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The active ingredient is Methylphenidate (INN for α-Phenyl-2-piperidineacetic acid methyl ester hydrochloride).

One tablet contains 10mg methylphenidate hydrochloride.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ritalin is indicated as a part of a comprehensive treatment programme for attention-deficit hyperactivity disorder (ADHD) in children aged 6 years of age and over when remedial measures alone prove insufficient.&nbsp; Treatment must be under the supervision of a specialist in childhood behavioural disorders.&nbsp; Diagnosis should be made according to DSM criteria or the guidelines in ICD and should be based on a complete history and evaluation of the patient. Diagnosis cannot be made solely on the presence of one or more symptom.</p><p>&nbsp;</p><p>The specific aetiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use of medical and specialised psychological, educational and social resources.</p><p>&nbsp;</p><p>A comprehensive treatment programme typically includes psychological, educational and social measures as well as pharmacotherapy and is aimed at stabilising children with a behavioural syndrome characterised by symptoms which may include chronic history of short attention span, distractibility, emotional lability, impulsivity, moderate to severe hyperactivity, minor neurological signs and abnormal EEG.&nbsp; Learning may or may not be impaired.</p><p>&nbsp;</p><p>Methylphenidate treatment is not indicated in all children with this syndrome and the decision to use the drug must be based on a very thorough assessment<strong> </strong>of the severity and the chronicity of the child&rsquo;s symptoms in relation to the child&rsquo;s age.</p><p>&nbsp;</p><p>Appropriate educational placement is essential, and psychosocial intervention is generally necessary. Where remedial measures alone prove insufficient, the decision to prescribe a stimulant must be based on rigorous assessment of the severity of the child&rsquo;s symptoms. The use of methylphenidate should always be used in the way according to the licensed indication and according to the prescribing/diagnostics guidelines.&nbsp;&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p><strong>Treatment must be initiated under the supervision of a specialist in childhood</strong></p><p><strong>and/or adolescent behavioural disorders</strong></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>&nbsp;</strong></p><p><strong>Pre-treatment screening</strong>:</p><p>Prior to prescribing, it is necessary to conduct a baseline evaluation of a patient&rsquo;s cardiovascular status including blood pressure and heart rate. A comprehensive history should document concomitant medications, past and present co-morbid medical and psychiatric disorders or symptoms, family history of sudden cardiac/unexplained death and accurate recording of pre-treatment height and weight on a growth chart (see sections 4.3 and 4.4).</p><p><strong><u>&nbsp;</u></strong></p><p><strong>Ongoing monitoring: </strong></p><p>Growth, psychiatric and cardiovascular status should be continuously monitored (see section 4.4).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood pressure and pulse should be recorded on a centile chart at each adjustment of dose and then at least every 6 months;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Height, weight and appetite should be recorded at least 6 monthly with maintenance of a growth chart;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Development of <em>de novo</em> or worsening of pre-existing psychiatric disorders should be monitored at every adjustment of dose and then at least every 6 months and at every visit.</p><p>&nbsp;</p><p>Patients should be monitored for the risk of diversion, misuse and abuse of methylphenidate.</p><p>&nbsp;</p><p><strong>Dose titration </strong></p><p>Careful dose titration is necessary at the start of treatment with methylphenidate. Dose titration should be started at the lowest possible dose.</p><p>&nbsp;</p><p>The maximum daily dose is 60mg.</p><p>&nbsp;</p><p>Other strengths of this medicinal product and other methylphenidate containing products may be available.</p><p>&nbsp;</p><p><em>Children</em>:&nbsp; (over 6 years).&nbsp; Begin with 5mg once or twice daily (e.g. at breakfast and lunch), increasing the dose and frequency of administration if necessary by weekly increments of 5-10mg in the daily dose.&nbsp; Doses above 60mg daily are not recommended.&nbsp; The total daily dose should be administered in divided doses.&nbsp; Ritalin is not indicated in children less than 6 years of age.&nbsp;</p><p>&nbsp;</p><p>If the effect of the drug wears off too early in the evening, disturbed behaviour and/or inability to go to sleep may recur.&nbsp; A small evening dose may help to solve this problem.&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>Long term (more than 12 months) use in children and adolescents </strong></p><p>The safety and efficacy of long term use of methylphenidate has not been systematically evaluated in controlled trials. Methylphenidate treatment should not and need not, be indefinite. Methylphenidate treatment is usually discontinued during or after puberty. The physician who elects to use methylphenidate for extended periods (over 12 months) in children and adolescents with ADHD should periodically re-evaluate the long term usefulness of the drug for the individual patient with trial periods off medication to assess the patient&rsquo;s functioning without pharmacotherapy. It is recommended that methylphenidate is de-challenged at least once yearly to assess the child&rsquo;s condition (preferable during school holidays). Improvement may be sustained when the drug is either temporarily or permanently discontinued.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>Dose reduction and discontinuation</strong></p><p>Treatment must be stopped if the symptoms do not improve after appropriate dosage adjustment over a one-month period. If paradoxical aggravation of symptoms or other serious adverse events occur, the dosage should be reduced or discontinued.</p><p>&nbsp;</p><p><strong>Adults</strong></p><p>Methylphenidate is not licensed for use in adults with ADHD. Safety and efficacy have not yet been established in this age group.</p><p>&nbsp;</p><p><strong>Elderly </strong></p><p>Methylphenidate should not be used in the elderly. Safety and efficacy has not been established in this age group.</p><p><strong>&nbsp;</strong></p><p><strong>Children under 6 years of age </strong></p><p>Methylphenidate should not be used in children under the age of 6 years. Safety and efficacy in this age group has not been established.</p><p>&nbsp;</p><p>Hepatic impairment</p><p>Ritalin has not been studied in patients with hepatic impairment. Caution should be exercised in these patients.</p><p>&nbsp;</p><p>Renal impairment</p><p>Ritalin has not been studied in patients with renal impairment. Caution should be exercised in these patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                •	Known sensitivity to methylphenidate or to any of the excipients in Ritalin.
•	Glaucoma
•	Phaechromocytoma
•	During treatment with non-selective, irreversible monoamine oxidase (MAO) inhibitors, or within a minimum of 14 days of discontinuing those drugs, due to risk of hypertensive crisis (see section 4.5)
•	Hyperthyroidism or thyrotoxicosis 
•	Diagnosis or history of severe depression, anorexia nervosa/anorexic disorders, suicidal tendencies, psychotic symptoms, severe mood disorders, mania, schizophrenia, psychopathic/borderline personality disorder.
•	Diagnosis or history of severe and episodic (Type 1) Bipolar (affective) disorder (that is not well controlled)
•	Pre-existing cardiovascular disorders including severe hypertension, heart failure, arterial occlusive disease, angina, haemodynamically significant congenital heart disease, cardiomyopathies, myocardial infarction, potentially life-threatening arrhythmias and channelopathies (disorders caused by the dysfunction of ion channels)
•	Pre-existing cerebrovascular disorders cerebral aneurysm, vascular abnormalities including vasculitis or stroke or known risk factors for cerebrovascular disorders

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Methylphendate treatment is not indicated in all children with ADHD and the decision to use the drug must be based on a very thorough assessment of the severity and chronicity of the child&rsquo;s symptoms in relation to the child&rsquo;s age.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Long term use (more than 12 months) in children and adolescents</strong></p><p>The safety and efficacy of long term use of methylphenidate has not been systematically evaluated in controlled trials. Methylphenidate treatment should not and need not be indefinite. Methylphenidate treatment is usually discontinued during or after puberty. Patients on long-term therapy (i.e. over 12 months) must have careful ongoing monitoring according to the guidance in section 4.2 and 4.4 for cardiovascular status, growth, appetite, development of <em>de</em> <em>nevo</em> or worsening of pre-existing psychiatric disorders. Psychiatric disorders to monitor for&nbsp; are described below, and include (but are not limited to) motor or vocal tics, aggressive or hostile behaviour, agitation, anxiety, depression, psychosis, mania, delusions, irritability, lack of spontaneity, withdrawal and excessive perseveration.</p><p>&nbsp;</p><p>The physician who elects to use methylphenidate for extended periods (over 12 months) in children and adolescents with ADHD should periodically re-evaluate the long term usefulness of the drug for the individual patient with trial periods off medication to assess the patient&rsquo;s functioning without pharmacotherapy. It is recommended that methylphenidate is de-challenged at least once yearly to assess the child&rsquo;s condition (preferably during times of school holidays). Improvement may be sustained when the drug is either temporary or permanently discontinued.</p><p><strong>&nbsp;</strong></p><p><strong>Use in adults </strong></p><p>Methylphenidate is not licenced for use in adults with ADHD. Safety and efficacy have not yet been established in this age group.</p><p>&nbsp;</p><p><strong>Use in the elderly </strong></p><p>Methylphenidate should not be used in the elderly. Safety and efficacy has not been established in this age group.</p><p>&nbsp;</p><p><strong>Use in children under 6 years of age </strong></p><p>Methylphenidate should not be used in children under the age of 6 years. Safety and efficacy in this age group has not been established.</p><p><strong>&nbsp;</strong></p><p><strong>Cardiovascular status </strong></p><p>Patients who are being considered for treatment with stimulant medications should have a careful history (including assessment for a family history of sudden cardiac or unexplained death or malignant arrthymia) and physical exam to assess for the presence of cardiac disease, and should receive further specialist cardiac evaluation if initial findings suggest such history or disease. Patients who develop symptoms such as palpitations, exertional chest pain, unexplained syncope, dyspnoea or other symptoms suggestive of cardiac disease during methylphenidate treatment should undergo a prompt specialist cardiac evaluation.</p><p>&nbsp;</p><p>Analyses of data from clinical trials of methylphenidate in children and adolescents with ADHD showed that patients using methylphenidate may commonly experience changes in diastolic and systolic blood pressure of over 10 mmHg relative to controls. The short and long term clinical consequences of these cardiovascular effects in children and adolescents are not known, but the possibility of clinical complications cannot be excluded as a result of the effects observed in the clinical trial data. <strong>Caution is indicated in treating patients whose underlying medical conditions might be compromised by increases in blood pressure or heart rate.</strong> See section 4.3 for conditions in which methylphenidate treatment is contraindicated.</p><p>&nbsp;</p><p><strong>Cardiovascular status should be carefully monitored. Blood pressure and pulse should be recorded on centile chart at each adjustment of dose and then at least every 6 months.</strong></p><p>&nbsp;</p><p>The use of methylphenidate is contraindicated in certain pre-existing cardiovascular disorders <strong>unless specialist paediatric advice has been obtained (see section 4.3 Contraindications).</strong></p><p><strong>&nbsp;</strong></p><p><strong>Sudden death and pre-existing cardiac structural abnormalities or other serious cardiac disorders</strong></p><p>Sudden death has been reported in association with the use of stimulants of the central nervous system at usual doses in children, some of whom had structural cardiac abnormalities or other serious heart problems.</p><p>Although some serious heart problems alone may carry an increased risk of sudden death, stimulant products are not recommended in children or&nbsp; adolescents with known cardiac structural abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to the sympathomimetic effects of a stimulant medicine.</p><p>&nbsp;</p><p><strong>Misuse and cardiovascular events:</strong></p><p>Misuse of stimulants of the central nervous system may be associated with sudden death and other serious cardiovascular adverse events.</p><p>&nbsp;</p><p><strong>Cerebrovascular disorders:</strong></p><p>See section 4.3 for cerebrovascular conditions in which methylphenidate treatment is contraindicated. Patients with additional risk factors (such as a history of cardiovascular disease, concomitant medications that elevate blood pressure) should be assessed at every visit for neurological signs and symptoms after initiating treatment with methylphenidate.</p><p>&nbsp;</p><p>Cerebral vasculitis appears to be very rare idiosyncratic reaction to methylphenidate exposure. There is little evidence to suggest that patients at higher risk can be identified and the initial onset of symptoms may be the first indication of an underlying clinical problem. Early diagnosis, based on a high index of suspicion, may allow the prompt withdrawal of methylphenidate and early treatment. The diagnosis should therefore be considered in any patient who develops new neurological symptoms that are consistent with cerebral ischemia during methylphenidate therapy. These symptoms could include severe headache, numbness, weakness, paralysis, and impairment of coordination, vision, speech, language or memory.</p><p>&nbsp;</p><p>Treatment with methylphenidate is not contraindicated in patients with hemiplegic cerebral palsy</p><p>&nbsp;</p><p><strong>Psychiatric disorders</strong></p><p>Co-morbidity of psychiatric disorders in ADHD is common and should be taken into account when prescribing stimulant products. In the case of emergent psychiatric symptoms or exacerbation of pre-existing psychiatric disorders, methylphenidate should not be given unless the benefits outweigh the risks to the patient.</p><p><strong>&nbsp;</strong></p><p><strong>Development or worsening of psychiatric disorders should be monitored at every adjustment of dose, then at least every 6 months, and at every visit: discontinuation of treatment may be appropriate. </strong></p><p><strong>&nbsp;</strong></p><p><strong>Exacerbation of pre-existing psychotic or manic symptoms</strong></p><p>In psychotic patients, administration of methylphenidate may exacerbate symptoms of behavioural disturbance and thought disorder.</p><p>&nbsp;</p><p><strong>Emergence of new psychotic or manic symptoms </strong></p><p>Treatment-emergent psychotic symptoms (visual/tactile/auditory hallucinations and delusions) or mania in children and adolescents without prior history of psychotic illness or mania can be caused by methylphenidate at usual doses. If manic or psychotic symptoms occur, consideration should be given to a possible causal role for methylphenidate and discontinuation of treatment may be appropriate.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Aggressive or hostile behaviour </strong></p><p>The emergence or worsening of aggression or hostility can be caused by treatment with stimulants. Patients treated with methylphenidate should be closely monitored for the emergence or worsening of aggressive behaviour or hostility at treatment initiation, at every dose adjustment and then least every 6 months and every visit. Physicians should evaluate the need for adjustment of the treatment regimen in patients experiencing behavioural changes bearing in mind that upwards or downwards tritration may be appropriate. Treatment interruption can be considered.</p><p>&nbsp;</p><p><strong>Suicidal tendency </strong></p><p>Patients with emergent suicidal ideation or behaviour during treatment for ADHD should be evaluated immediately by their physician. Consideration should be given to the exacerbation of an underlying psychiatric condition and to a possible causal role of methylphenidate treatment. Treatment of an underlying psychiatric condition may be necessary and consideration should be given to a possible discontinuation of methylphenidate.</p><p>&nbsp;</p><p><strong>Tics</strong></p><p>Methylphenidate is associated with the onset or exacerbation of motor and verbal tics. Worsening of Tourette&rsquo;s syndrome has also been reported. Family history should be assessed and clinical evaluation for tics or Tourette&rsquo;s syndrome in children should precede use of methylphenidate. Patients should be regularly monitored for the emergence or worsening of tics during treatment with methylphenidate. <strong>Monitoring should be at every adjustment of dose and then at least every 6 months or every visit.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Anxiety, agitation or tension </strong></p><p>Methylphenidate is associated with the worsening of pre-existing anxiety, agitation or tension. Clinical evaluation for anxiety, agitation or tension should precede use of methylphenidate and patients should be <strong>regularly monitored for the emergence or worsening of these symptoms during treatment, at every adjustment of dose and then at least every 6 months or every visit. </strong></p><p><strong>&nbsp;</strong></p><p><strong>Forms of bipolar disorder</strong></p><p>Particular care should be taken in using methylphenidate to treat ADHD in patients with co morbid bipolar disorder (including untreated type 1 bipolar disorder or other forms of bipolar disorder) because of concern for possible precipitation of a mixed/manic episode in such patients. Prior to initiating treatment with methylphenidate, patients with co morbid depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression. <strong>Close ongoing monitoring is essential in these patients (see above &lsquo;Psychiatric Disorders&rsquo; and section 4.2). Patients should be monitored for symptoms at every adjustment of dose, then at least every 6 months and at every visit. </strong></p><p><strong>&nbsp;</strong></p><p><strong>Priapism</strong></p><p>Prolonged and painful erections have been reported in association with methylphenidate products, mainly in association with a change in the methylphenidate treatment regimen. Patients who develop abnormally sustained or frequent and painful erections should seek immediate medical attention.</p><p><strong>&nbsp;</strong></p><p><strong>Growth</strong></p><p>Moderately reduced weight gain and growth retardation have been reported with long-term use of methylphenidate in children.</p><p>&nbsp;</p><p>The effects of methylphenidate on final height and final weight are currently unknown and being studied.</p><p>&nbsp;</p><p><strong>Growth should be monitored during methylphenidate treatment: height, weight and appetite should be recorded at least 6 monthly with maintenance of a growth chart. </strong>Patients who are not growing or gaining height or weight as expected may need to have their treatment interrupted.</p><p>&nbsp;</p><p><strong>Seizures</strong></p><p>Methylphenidate should be used with caution in patients with epilepsy. Methylphenidate may lower the convulsive threshold in patients with prior history of seizures, in patients with prior EEG abnormalities in absence of seizures, and rarely in patients without a history of convulsions and no EEG abnormalities. If seizure frequency increases or new-onset seizures occur, methylphenidate should be discontinued.&nbsp;&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>Abuse, misuse and diversion</strong></p><p>Patients should be carefully monitored for the risk of diversion, misuse and abuse of methylphenidate.</p><p>&nbsp;</p><p>Methylphenidate should be used with caution in patients with known drug or alcohol dependency because of a potential for abuse, misuse or diversion.</p><p>&nbsp;</p><p>Chronic abuse of methylphenidate can lead to marked tolerance and psychological dependence with varying degrees of abnormal behaviour. Frank psychotic episodes can occur, especially in response to parenteral abuse.</p><p>&nbsp;</p><p>Patient age, the presence of risk factors for substance use disorder (such as co-morbid oppositional-defiant or conduct disorder and bipolar disorder), previous or current substance abuse should be taken in to account when deciding on a course of treatment for ADHD. Caution is called for in emotionally unstable patients, such as those with a history of drug or alcohol dependence, because such patients may increase the dosage on their own initiative.</p><p>&nbsp;</p><p>For some high-risk substance abuse patients, methylphenidate or other stimulants may not be suitable and non-stimulant treatment should be considered.</p><p><strong>&nbsp;</strong></p><p><strong>Withdrawal</strong></p><p>Careful supervision is required during withdrawal, since this may unmask depression as well as chronic over-activity. Some patients may require long-term follow-up.</p><p>&nbsp;</p><p>Careful supervision is required during withdrawal from abusive use since severe depression may occur.</p><p>&nbsp;</p><p><strong>Fatigue</strong></p><p>Methylphenidate should not be used for the prevention or treatment of normal fatigue states.</p><p>&nbsp;</p><p><strong>Excipients: glactose/sucrose intolerance</strong></p><p>This medicinal product contains lactose: patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-glactose malabsorption should not take this medicine.</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;</p><p><strong>Choice of methylphenidate formulation</strong></p><p>The choice of formulation of methylphenidate-containing product will have to be decided by the treating specialist on an individual basis and depends on the intended duration of effect.</p><p>&nbsp;</p><p><strong>Drug screening</strong></p><p>This product contains methylphenidate which may induce a false positive laboratory test for amphetamines, particularly with immunoassay screen test.</p><p>&nbsp;</p><p><strong>Renal or hepatic insufficiency</strong></p><p>There is no experience with the use of methylphenidate in patients with renal or hepatic insufficiency.</p><p><strong>&nbsp;</strong></p><p><strong>Haematological effects</strong></p><p>The long-term safety of treatment with methylphenidate is not fully known. In the event of leucopenia, thrombocytopenia, anaemia or other alterations, including those indicative of serious renal or hepatic disorders, discontinuation of treatment should be considered.</p><p>&nbsp;</p><p><strong>Potential for gastrointestinal obstruction </strong></p><p>Because Ritalin tablet is nondeformable and does not appreciably change in shape in the gastrointestinal (GI) tract, it should not ordinarily be administered to patients pre-existing severe GI narrowing (pathologic or iatrogenic) or in patients with dsyphagia or significant difficulty in swallowing tablets. There have been rare reports of obstructive symptoms in patients with known strictures in association with the ingestion of drugs in nondeformable prolonged-release formulations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacokinetic interaction</strong></p><p>It is not known how methylphenidate may effect plasma concentrations of concomitantly administered drugs. Therefore, caution is recommended at combining methylphenidate with other drugs, especially those with narrow therapeutic window.</p><p>&nbsp;</p><p>Methylphenidate is not metabolised by cytochrome P450 to a clinically relevant extent. Inducers or inhibitors of cytochrome P450 are not expected to have any relevant impact on methylphenidate pharmacokinetics. Conversely, the d- and I- enantiomers of methylphenidate do not relevantly inhibit cytochrome P450 1A2, 2C8, 2C9, 2C19, 2D6, 2E1 or 3A.</p><p>&nbsp;</p><p>However, there are reports indicating that methylphenidate may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (e.g. Phenobarbitol, phenytoin, primodone), and some antidepressants (tricyclic and selective serotonin reuptake inhibitors).</p><p>&nbsp;</p><p>When starting and stopping treatment with methylphenidate, it may be necessary to adjust the dosage of these drugs already being taken and establish drug plasma concentrations (or for coumarin, coagulation times).</p><p>&nbsp;</p><p><strong>Pharmacodynamics interactions</strong></p><p><strong>&nbsp;</strong></p><p><strong>Anti-hypertensive drugs</strong></p><p>Methylphenidate may decrease the effectiveness of drugs used to treat hypertension.</p><p>&nbsp;</p><p><strong>Use with drugs that elevate blood pressure</strong></p><p>Caution is advised in patients being treated with methylphenidate with other drugs that can also elevate blood pressure (see also sections on cardiovascular and cerebrovascular conditions in section 4.4 Warnings and precautions for use).</p><p>&nbsp;</p><p>Because of possible hypertensive crisis, methylphenidate is contraindicated in patients being treated (currently or within the preceding 2 weeks) with non-selective, irreversible MAO-inhibitors (see section 4.3 Contraindications).</p><p>&nbsp;</p><p><strong>Use with alcohol</strong></p><p>Alcohol may exacerbate the adverse CNS effects of psychoactive drugs, including methylphenidate. It is therefore advisable for patients to abstain from alcohol during treatment</p><p>&nbsp;</p><p><strong>Use with halogenated anaesthetics </strong></p><p>There is a risk of sudden blood pressure increase during surgery. If surgery is planned, methylphenidate treatment should not be used on the day of surgery.</p><p>&nbsp;</p><p><strong>Use with centrally acting alpha-2agonists (e.g. clonidine)</strong></p><p>The long term safety of using methylphenidate in combination with clonidine or other centrally acting alpha-2 agonists has not been systematically evaluated.</p><p>&nbsp;</p><p><strong>Use with dopaminergic drugs</strong></p><p>Caution is recommended when administering methylphenidate with dopaminergic drugs, including antipsychotics. Because a predominant action of methylphenidate is to increase extra cellular dopamine levels, methylphenidate may be associated with pharmacodynamic interactions when co-administered with direct and indirect dopamine agonists (including DOPA and tricyclic antidepressants) or with dopamine antagonists including antipsychotics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>&nbsp;</p><p>Data from a cohort study of a total of approximately 3,400 pregnancies exposed in the first trimester do not suggest an overall increased risk of birth defects. The frequency of cardiac malformations was slightly increased (pooled adjusted relative risk: 1.3; 95% CI: 1.0, 1.6) corresponding to 3 additional infants with congenital cardiac malformations for every 1,000 women who receive methylphenidate in the first trimester compared with non-exposed pregnancies. There are spontaneous reports of cardiorespiratory toxicity in neonates; fetal tachycardia and dyspnoea were reported in particular.</p><p>&nbsp;</p><p>Studies in animals have only shown evidence of reproductive toxicity at maternally toxic doses. (See Section 5.3, Preclinical Safety Data).</p><p>&nbsp;</p><p>Methylphenidate is not recommended for use during pregnancy unless a clinical decision is made that postponing treatment may pose a greater risk to the pregnancy.</p><p>&nbsp;</p><p><strong>Lactation</strong></p><p>Methylphenidate has been found in breast-milk of a women treated with methylphenidate.</p><p>&nbsp;</p><p>There is one case report of an infant who experienced an unspecified decrease in weight during the period of exposure but recovered and gained weight after the mother discontinued treatment with Methylphenidate. A risk to the suckling child cannot be excluded.</p><p>&nbsp;</p><p>A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from methylphenidate therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.</p><p>&nbsp;</p><p><strong>Fertility</strong></p><p>No human data on the effect of methylphenidate on fertility are available. Methylphenidate did not impair fertility in male or female mice (see Section 5.3 Preclinical Safety Data<strong>).</strong></p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ritalin may cause dizziness, drowsiness and visual disturbances including difficulties with accommodation, diplopia and blurred vision. It may have a moderate influence on the ability to drive and use machines. Patients should be warned of these possible effects and advised that if affected, they should avoid potentially hazardous activities such as driving or operating machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The table below shows all adverse drug reactions (ADRs) observed during clinical trials and post market spontaneous reports with methylphenidate and those, which have been reported with other methylphenidate hydrochloride formulations. If ADRs with methylphenidate and the methylphenidate formulation frequencies were different, the highest frequency of both databases was used.</p><p><strong>&nbsp;</strong></p><p>Frequency estimate:&nbsp; very common (&sup3; 1/10); common (&sup3; 1/100 to &lt; 1/10); uncommon (&sup3; 1/1000 to &lt;1/100); rare (&sup3; 1/10,000 to &lt;1/1000); very rare (&lt; 1/10,000); not known (cannot be estimated from available data).</p><p>&nbsp;</p><p><strong>Infections and infestations</strong></p><p><em>Common</em>: Nasopharyngitis</p><p>&nbsp;</p><p><strong>Blood and lymphatic disorders</strong></p><p><em>Very rare</em>: Anaemia, leucopenia, thrombocytopenia, thrombocytopenic purpura</p><p><em>Unknown</em>: Pancytopenia</p><p>&nbsp;</p><p><strong>Immune system disorders</strong></p><p><em>Uncommon</em>: Hypersensitivity reactions such as angioneurotic oedema, anaphylactic reactions, auricular swelling, bullous conditions, exfoliative conditions, urticaria, pruritis, rashes and eruptions</p><p>&nbsp;</p><p><strong>Metabolism and nutritional disorders *</strong></p><p><em>Common</em>: Anorexia, decreased appetite, moderately reduced weight and height gain during prolonged use in children</p><p>&nbsp;</p><p><strong>Psychiatric disorders *</strong></p><p><em>Very common</em>: Insomnia, nervousness</p><p><em>Common</em>: Anorexia, affect lability, aggression*, agitation*, anxiety*, depression*, irritability, abnormal behaviour, bruxism**.</p><p><em>Uncommon</em>: Psychotic disorders<strong>*</strong>, auditory, visual, and tactile hallucinations<strong>*</strong>, anger, suicidal ideation<strong>*</strong>, mood altered, mood swings, restlessness, tearfulness, tics<strong>*</strong>, worsening of pre-existing tics or Tourette&rsquo;s syndrome<strong>*</strong>, hypervigilance, sleep disorder</p><p><em>Rare</em>: Mania<strong>*</strong>, disorientation, libido disorder</p><p><em>Very rare</em>: Suicidal attempt (including completed suicide)<strong>*</strong>, transient depressed mood<strong>*</strong>, abnormal thinking<em>, </em>apathy, repetitive behaviours, over-focusing</p><p><em>Not known</em>: Delusions<strong>*</strong>, thought disturbances<strong>*</strong>, confusional state, dependence, logorrhea.</p><p>Cases of abuse and dependence have been described, more often with immediate release formulations (frequency not known)</p><p>&nbsp;</p><p><strong>Nervous system disorders</strong>:</p><p><em>Very common</em>: Headache</p><p><em>Common</em>: Dizziness, dyskinesia, psychomotor hyperactivity, somnolence</p><p><em>Uncommon</em>: Sedation, tremor</p><p><em>Very rare</em>: Convulsions, choreo-athetoid movements, reversible ischaemic neurological deficit, neuroleptic malignant syndrome (NMS: Reports were poorly documented and in most cases, patients were also receiving other drugs, so the role of methylphenidate is unclear).</p><p><em>Not known</em>: Cerebrovascular disorders<em>* </em>(including vasculitis, cerebral haemorrhages, cerebrovascular accidents, cerebral arteritis, cerebral occlusion), grand mal convulsions*, migraine, dysphemia.</p><p>&nbsp;</p><p><strong>Eye disorders</strong></p><p><em>Uncommon</em>: Diplopia, blurred vision</p><p><em>Rare</em>:<em> </em>Difficulties in visual accommodation, mydriasis, visual disturbance</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Cardiac disorders*</strong></p><p><em>Common</em>: Arrhythmia, tachycardia palpitations</p><p><em>Uncommon</em>:<em> </em>Chest pain</p><p><em>Rare</em>: Angina pectoris</p><p><em>Very rare</em>: Cardiac arrest, myocardial infarction</p><p><em>Not known</em>: Supraventricular tachycardia, bradycardia, ventricular extrasystoles, extrasystoles</p><p>&nbsp;</p><p><strong>Vascular disorders*</strong></p><p><em>Common</em>: Hypertension</p><p><em>Very rare</em>: Cerebral arteritis and/or occlusion, peripheral coldness, Raynaud&rsquo;s phenomenon</p><p>&nbsp;</p><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p><p><em>Common</em>: Cough, pharyngolaryngeal pain</p><p><em>Uncommon</em>: Dyspnoea</p><p>&nbsp;Not known: Epistaxis</p><p>&nbsp;</p><p><strong>Gastro-intestinal disorders</strong>:</p><p><em>Common</em>: Abdominal pain, diarrhoea, nausea, stomach discomfort and vomiting.&nbsp; These usually occur at the beginning of treatment and may be alleviated by concomitant food intake. Dry mouth.</p><p><em>Uncommon</em>: Constipation</p><p>&nbsp;</p><p><strong>Hepatobiliary disorders</strong></p><p><em>Uncommon</em>: Hepatic enzyme elevations</p><p><em>Very rare</em>: Abnormal liver functions, including hepatic coma</p><p>&nbsp;</p><p><strong>Skin and subcutaneous tissue disorders</strong></p><p><em>Common</em>: Alopecia, pruritis, rash, urticaria</p><p><em>Uncommon</em>: Angioneurotic oedema, bullous conditions, exfoliate conditions</p><p><em>Rare</em>: Hyperhidrosis, macular rash, erythema</p><p><em>Very rare</em>: Erythema multiforme, exfoliate dermatitis, fixed drug eruption</p><p>&nbsp;</p><p><strong>Musculoskeletal, connective tissue and bone disorders</strong></p><p><em>Common</em>: Arthralgia</p><p><em>Uncommon</em>: Myalgia, muscle twitching,</p><p><em>Very rare</em>: Muscle cramps</p><p><em>Not known</em>: Trismus**</p><p>&nbsp;</p><p><strong>Renal and urinary disorders</strong></p><p><em>Uncommon</em>: Haematuria</p><p><em>Unknown: </em>Incontinence</p><p>&nbsp;</p><p><em>&nbsp;</em></p><p><strong>Reproductive system and breast disorders</strong></p><p><em>Rare</em>: Gynaecomastia</p><p><em>Unknown</em>: Erectile dysfunction, priapism, erection increased and prolonged erection</p><p>&nbsp;</p><p><strong>General disorders and administration site conditions</strong></p><p><em>Common</em>: Pyrexia, growth retardation during prolonged use in children*</p><p><em>Uncommon</em>: Chest pain, fatigue</p><p><em>Very rare</em>: Sudden cardiac death*</p><p><em>Not known</em>: Chest discomfort, hyperpyrexia</p><p>&nbsp;</p><p><strong>Investigations</strong></p><p><em>Common</em>:<em> </em>Changes in blood pressure and heart rate (usually an increase)*, weight decreased*</p><p><em>Uncommon</em>: Cardiac murmur*, hepatic enzyme increased</p><p><em>Very rare</em>: Blood alkaline phosphatase increased, blood bilirubin increased, platelet count decreased, white blood count abnormal</p><p>&nbsp;</p><p>* See section 4.4 &ldquo;Special warnings and precautions for use&rdquo;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;</p><p>** Based on the frequency calculated in adult ADHD studies (no cases were reported in the paediatric studies)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;</p><p>To report any side effect(s):</p><p>Saudi Arabia</p><p>&nbsp;</p><p>The National Pharmacovigilance Centre (NPC):</p><p>&nbsp;</p><p>o Fax: +966-11-205-7662</p><p>o SFDA call center: 19999</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: https://ade.sfda.gov.sa</p><p>&nbsp;</p><p>Patient Safety Department Novartis Consulting AG - Saudi Arabia:</p><p>&nbsp;</p><p>o Toll Free Number: 8001240078</p><p>o Phone: +966112658100</p><p>o Fax: +966112658107</p><p>o Email: adverse.events@novartis.com</p><p>&nbsp;</p><p>&bull;&nbsp;&nbsp;&nbsp; Other GCC States:</p><p>-&nbsp; Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>When treating patients with overdose, allowances must be made for the delayed release of methylphenidate from formulations with extended durations of action. &nbsp;</p><p>&nbsp;</p><p><strong>Signs and symptoms</strong></p><p>Acute overdose, mainly due to overstimulation of the central and sympathetic nervous systems, may result in vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, dryness of mucous membranes and rhabdomyolysis&nbsp;</p><p>&nbsp;</p><p><strong>Treatment</strong></p><p>There is no specific antidote to methylphenidate overdosage.&nbsp;</p><p>&nbsp;</p><p>Treatment consists of appropriate supportive measures.</p><p>The patient must be protected against self-injury and against external stimuli that would aggravate over-stimulation already present.&nbsp; If the signs and symptoms are not too severe and the patient is conscious, gastric contents may be evacuated by induction of vomiting or gastric lavage. Before performing gastric lavage, control agitation and seizures if present and protect the airway.&nbsp; Other measures to detoxify the gut include administration of activated charcoal and a cathartic. In the presence of severe intoxication, a carefully titrated dose of a benzodiazepine should be given before performing gastric lavage.</p><p>&nbsp;</p><p>Intensive care must be provided to maintain adequate circulation and respiratory exchange; external cooling procedures may be required to reduce hyperpyrexia.&nbsp;</p><p>&nbsp;</p><p>Efficacy of peritoneal dialysis or extracorporeal haemodialysis for overdose of methylphenidate has not been established.&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: psychostimulants - ATC code: NO6B AO4.</p><p>&nbsp;</p><p><em>Mode of action: </em>Methylphenidate is a mild CNS stimulant with more prominent effects on mental than on motor activities.&nbsp; Its mode of action in man is not completely understood but its effects are thought to be due to an inhibition of dopamine reuptake in the striatum, without triggering the release of dopamine.</p><p>&nbsp;</p><p>The mechanism by which methylphenidate exerts its mental and behavioural effects in children is not clearly established, nor is there conclusive evidence showing how these effects relate to the condition of the central nervous system.</p><p>&nbsp;</p><p>Methylphenidate is a racemic mixture containing d- and l-enantiomers, where the d-enantiomer is considered as the pharmacologically active enantiomer.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption:</strong></p><p>The active substance methylphenidate hydrochloride is rapidly and almost completely absorbed from the tablets.&nbsp; Owing to extensive first-pass metabolism the absolute bioavailability was 22&plusmn;8&nbsp;% for the d-enantiomer and 5&plusmn;3 % for the l‑enantiomer. Ingestion together with food increased both the peak plasma concentration(C<sub>max</sub>) by 23% and the area under the concentration-time curve (AUC) by 15%, but had no relevant effect on the rate of absorption of&nbsp; methylphenidate.Peak plasma concentrations of approximately 40nmol/litres (11ng/ml) are attained, on average, 1-2 hours after administration of 0.30mg/kg.&nbsp; The peak plasma concentrations, however, show considerable intersubject variability.&nbsp; The AUC and the Cmax, are proportional to the dose.&nbsp;</p><p>&nbsp;</p><p><strong>Distribution</strong>:</p><p>In the blood, methylphenidate and its metabolites become distributed in the plasma (57%) and the erythrocytes (43%).&nbsp; Methylphenidate and its metabolites have a low plasma protein-binding rate (10-33%).&nbsp; The volume of distribution was 2.65&plusmn;1.11 L/kg for d-MPH and 1.80&plusmn;0.91 L/kg for l-MPH.</p><p>&nbsp;</p><p><strong>Biotransformation</strong></p><p>Biotransformation of methylphenidate by the carboxylesterase CES1A1 is rapid and extensive.&nbsp; Peak plasma concentrations of &alpha;-phenyl-2-piperidyl acetic acid (ritalinic acid) (PPAA) are attained approximately 2 hours after administration of methylphenidate and are 30-50 times higher than those of the unchanged substance.&nbsp; The half-life of PPAA is roughly twice as long as that of methylphenidate, and the mean systemic clearance is 0.17 litres/h/kg.&nbsp; Only small amounts of hydroxylated metabolites (e.g. hydroxymethylphenidate and hydroxyritalinic acid) are detectable.&nbsp; Therapeutic activity seems to be principally due to the parent compound.</p><p>&nbsp;</p><p><strong>Elimination:</strong></p><p>Methylphenidate is eliminated from the plasma with a mean half-life of 2 hours, The systemic clearance is 0.40<u>&plusmn;</u>0.12 L/h/kg for d-MPH and 0.73<u>&plusmn;</u>0.28 L/h/kg for l-MPH. Within 48-96 hours 78-97% of the dose administered is excreted in the urine and 1-3% in the faeces in the form of metabolites.&nbsp; Unchanged methylphenidate appears in the urine only in small quantities (&lt;1%).&nbsp; The bulk of the dose is excreted in the urine as PPAA, (60-86%).</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>Characteristics in patients:</strong></p><p>There are no apparent differences in the pharmacokinetic behaviour of methylphenidate in hyperactive children and healthy adult volunteers.&nbsp;</p><p>&nbsp;</p><p>Elimination data from patients with normal renal function suggest that renal excretion of the unchanged methylphenidate would hardly be diminished at all in the presence of impaired renal function.&nbsp; However, renal excretion of PPAA may be reduced.&nbsp;</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Carcinogenicity </strong></p><p>In life-time rat and mouse carcinogenicity studies, increased numbers of malignant liver tumours, were noted in male mice only. The significance of this finding to humans is unknown.</p><p>Methylphenidate did not affect reproductive performance or fertility at low multiples of the clinical dose.</p><p><strong>&nbsp;</strong></p><p><strong>Pregnancy-embryonal/foetal development </strong></p><p>Methylphenidate is not considered to be teratogenic in rats and rabbits. Foetal toxicity (i.e. total litter loss) and maternal toxicity was noted in rats at maternally toxic doses.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The tablets also contain calcium phosphate<strong> </strong>tribasic special, lactose, wheat starch, gelatin, magnesium stearate and talc.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; None known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                          18 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Do not store above 30<sup>o</sup>C.&nbsp; Store in the original package in order to protect from mositure</li><li>Keep this medicine out of sight and reach of children.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ritalin tablets are available in blister packs of 30 tablets in PA/AL/PVC blisters backed with aluminium foil.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The Marketing Authorization Holder for this Product is Novartis Pharma AG. 
www.Novartis.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                December 2022 by Switzerland
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>